drugset / Trial / NCT00466193

A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

NCT00466193

Phase 3 Completed 295 enrolled Transcept Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate sleep onset following administration of zolpidem tartrate sublingual tablet (Intermezzo) versus placebo in adult insomnia patients.

Timeline

Start
2007-05
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 3.5 mg Other

Indications